The Systematic Review
In Brief This article is the first in a new series on systematic reviews from the Joanna Briggs Institute, an international collaborative supporting evidence-based practice in n...
Publications
Explore 247 academic publications
Showing 12 of
247 publications
Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)
Abstract A method to obtain the optimal selection criteria, taking into account available resources and capacity and the impact on power, is presented for the Dutch‐Belgian rand...
Immune Regulation of Cancer
Innate and adaptive immune system cells play a major role in regulating the growth of cancer. Although it is commonly thought that an immune response localized to the tumor will...
Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants
Journal Article Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants Get access Glenn H. ...
Cancer Mortality in the United States by Education Level and Race
Cancer death rates vary considerably by level of education. Identifying groups at high risk of death from cancer by level of education as well as by race may be useful in target...
Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted?
Abstract . Zimmet P (International Diabetes Institute, Melbourne, Australia). Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be ave...
Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1
Using uPA and PAI-1, we have been able to classify about half of the patients with lymph node-negative breast cancer as low risk, for whom adjuvant chemotherapy may be avoided, ...